Tag Archives: False Claims Act

Under Investigation: 180 Qui Tams for Pharma or Device Fraud


In May 2009, the Department of Justice (DOJ) and Human Health and Human Services (HHS) announced the creation of the Health Care Fraud Prevention and Enforcement Action Team (HEAT).  As part of a larger effort by the Obama administration, HEAT and its parent organizations have made the fight against Medicare fraud a Cabinet-level priority.  The purpose of HEAT is to build upon existing partnerships between the DOJ and HHS and gather resources across the government to help prevent waste, fraud and abuse in the Medicare and Medicaid programs. Continue reading

17x Return on DOJ Fraud


Fraud and abuse has been a hot topic for Congressional oversight, and the DOJ is performing admirably by stockpiling revenues — $2.5B in FY2010 alone for civil healthcare fraud with $1.6MM courtesy of pharma and medical device companies.  Additionally, with the DOJ’s outstanding returns, $17 for every dollar spent on enforcement from FY2007-FY2009 (check out page 31 of their appropriations report), the DOJ’s ROI looks better than most pharma and medical device companies. Continue reading